Back to caseload

AP-003

Pediatric leukemia, rural, Medicaid, over 150 miles

CAR-T · Phase 2, Candidacy Evaluation · 26 days in stage · 17 barriers, 6 blocking

Falling behind26 days in work-up to candidacy decision, past the 21-day target

The engine, inverted

By factor

Each row is one fact about this patient and everything it sets in motion. 12 of 22 factors drive more than one barrier, which is where addressing the cause beats addressing the symptoms.

Below poverty level

drives 4 barriers

Household income

  • Financial toxicity / out-of-pocket burdenHigh

    Below poverty, even modest out-of-pocket costs force impossible trade-offs that can derail treatment

  • Equity / disparity riskHigh

    Low income stacks travel, lodging, time-off, and coverage hurdles that each thin the odds of finishing care

  • Travel & lodging burdenHigh

    Below poverty, front-loaded travel and lodging costs are often simply unaffordable without assistance lined up first

  • Housing insecurity / relocation burdenModerate

    On a low income, paying for weeks of lodging away from home is usually out of reach without help

Medicaid coverage

drives 4 barriers

Insurance

  • Single-case agreement / out-of-networkHigh

    Medicaid out-of-state billing and enrollment are notoriously slow, stretching the time before treatment can start

  • Insurance coverage & prior-authorizationHigh

    Medicaid rules vary by state and plan — some don't clearly cover CAR-T, so approval can be slow or contested

  • Coverage lag after approvalModerate

    State Medicaid can take months after FDA approval to add a new therapy, so coverage may not exist yet when it's needed

  • Equity / disparity riskHigh

    Medicaid patients meet more coverage restrictions and site limits, which lowers the chance of reaching treatment

Over 150 miles / out of state

drives 4 barriers

Distance to nearest center

  • Single-case agreement / out-of-networkHigh

    A distant, out-of-area site adds cross-plan paperwork that has to clear before scheduling can even begin

  • Geographic access / distance to a centerHigh

    Over 150 miles or out-of-state turns care into a relocation, and uptake falls sharply as distance grows

  • Travel & lodging burdenHigh

    Over 150 miles usually means weeks of lodging near the center — a large, front-loaded out-of-pocket cost

  • Housing insecurity / relocation burdenModerate

    Over 150 miles means weeks living near the center — a housing arrangement that has to be secured up front

Rural home community

drives 4 barriers

Home community

  • Geographic access / distance to a centerHigh

    Rural homes sit far from the few certified centers, so the nearest option may be hours away

  • Equity / disparity riskHigh

    Rural residence layers distance, workforce, and coverage gaps on top of other disadvantages

  • Travel & lodging burdenHigh

    Rural patients travel farther at every step, compounding cost and time away from work and family

  • Transportation barrierModerate

    Rural areas have little public transit, so the long drives fall entirely on the family

Limited health literacy

drives 3 barriers

Health-system navigation

  • Equity / disparity riskHigh

    Harder to grasp eligibility, ask the right questions, and self-advocate — so these patients are identified and referred less often

  • Language & communication barrierModerate

    Dense medical explanations may not land, so key instructions and warning signs can be missed unless teach-back is used

  • Health-literacy / navigation-complexity burdenModerate

    The pathway spans dozens of visits, forms, and authorizations; without hands-on navigation, steps get missed and patients fall behind

Rapidly progressive disease

drives 3 barriers

Disease pace

  • Late referral / progression before treatmentHigh

    Fast-moving disease can outrun the refer-and-work-up timeline, so any delay risks losing the treatment window

  • Eligibility / patient-selection hurdlesWatch

    Rapid progression can erode fitness mid-work-up, so someone eligible today may not be by the time they are assessed

  • Manufacturing / collection & vein-to-vein riskModerate

    The 2–8 week manufacturing wait is hard to survive when disease is moving fast, which makes strong bridging therapy critical

Dependents at home

drives 2 barriers

Young children / dependents at home needing care

  • Caregiver & psychosocial clearanceHigh

    Children or dependents at home make a month-long relocation and 24/7 caregiving hard to arrange

  • Housing insecurity / relocation burdenModerate

    Dependents at home make an extended relocation harder to sustain, both logistically and financially

Limited English proficiency

drives 2 barriers

Language

  • Language & communication barrierModerate

    Without interpreters, eligibility discussions, consent, and toxicity instructions may not be understood — risking errors and delay

  • Health-literacy / navigation-complexity burdenModerate

    A language barrier adds a translation layer to every form and instruction, slowing an already complex process

New to cell / gene therapy

drives 2 barriers

Family understanding of CAR-T

  • Health-literacy / navigation-complexity burdenModerate

    Brand-new to cell therapy, the family has a lot to absorb quickly just to keep decisions on schedule

  • Awareness, understanding & hesitancyWatch

    New to CAR-T, the family may over- or under-estimate risk and benefit, which makes decisions harder and slower

No center in home state

drives 2 barriers

Center in home state?

  • Single-case agreement / out-of-networkHigh

    Out-of-state treatment usually requires enrolling the provider in the patient's plan or Medicaid — a slow, extra step

  • Geographic access / distance to a centerHigh

    No in-state center forces out-of-state care, adding travel plus cross-state coverage and enrollment steps

Out-of-network / out-of-state center

drives 2 barriers

Center network status

  • Single-case agreement / out-of-networkHigh

    Out-of-network care requires negotiating a single-case agreement before treatment — often several weeks of back-and-forth

  • Insurance coverage & prior-authorizationHigh

    An out-of-network center means standard authorization doesn't apply — a special agreement has to be arranged first

Pediatric heme malignancy

drives 2 barriers

Diagnosis

  • Coverage lag after approvalModerate

    Newer pediatric indications are added to policies last, so coverage can lag behind the child's actual need

  • Pediatric / young-adult access gapModerate

    A pediatric blood cancer has a narrower set of approved options, concentrating care at a few specialized centers

2+ prior lines of therapy

drives 1 barrier

Line of therapy

  • Late referral / progression before treatmentHigh

    With 2+ lines already used, the window to refer while still eligible is closing

Caregiver availability uncertain

drives 1 barrier

Dedicated caregiver (~30 days)

  • Caregiver & psychosocial clearanceHigh

    An unconfirmed caregiver can hold up psychosocial clearance until a concrete, named plan is in place

Caregiver would lose income

drives 1 barrier

Caregiver & work

  • Caregiver & psychosocial clearanceHigh

    If the caregiver can't take ~a month of leave without losing income, the required round-the-clock coverage can fall through

Little / no savings

drives 1 barrier

Financial cushion

  • Financial toxicity / out-of-pocket burdenHigh

    With little savings, one unexpected bill or lost paycheck can halt participation mid-course

Managed in a community setting

drives 1 barrier

Currently managed at

  • Late referral / progression before treatmentHigh

    Community teams see CAR-T rarely, so an eligible patient is easy to overlook or refer only after more lines are used

Minority race / ethnicity

drives 1 barrier

minority

  • Equity / disparity riskHigh

    Documented referral bias and trial under-representation mean minority patients reach CAR-T less often at each step of the path

Pediatric (under 18)

drives 1 barrier

Age band

  • Pediatric / young-adult access gapModerate

    Few products are approved for children, so care often means a clinical trial at a distant pediatric center

Referring team unfamiliar with CAR-T

drives 1 barrier

Referring team & CAR-T

  • Late referral / progression before treatmentHigh

    A team unfamiliar with CAR-T may not spot candidacy or know when and where to send the patient

Relies on others / transit

drives 1 barrier

Transportation

  • Transportation barrierModerate

    Depending on others or transit makes frequent, time-sensitive visits fragile — a missed ride becomes a missed step

Would lose income during treatment

drives 1 barrier

Income during treatment

  • Financial toxicity / out-of-pocket burdenHigh

    Weeks away from work with no paid leave cut household income at exactly the moment costs are spiking